# Muhammad Shahzil

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/muhammad-shahzil/

## Facts

| Field | Value |
| --- | --- |
| Citations | 157 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 5 |
| i10-index | 3 |
| Last Known Institution | Pennsylvania State University |
| OpenAlex ID | https://openalex.org/A5033367448 |
| ORCID iD | 0000-0002-4010-7545 |
| Works | 104 |

## Researcher papers

- [Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis](https://scholariq.org/papers/global-prevalence-and-risk-factors-of-irritable-bowel-syndrome-from-2006-to-2024/)
- [Quercetin for the treatment of COVID‐19 patients: A systematic review and meta‐analysis](https://scholariq.org/papers/quercetin-for-the-treatment-of-covid-19-patients-a-systematic-review-and-meta/)
- [Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice](https://scholariq.org/papers/non-pharmacological-approach-to-diet-and-exercise-in-metabolic-associated-fatty/)
- [Catastrophic Floods in Pakistan: An Urgent Appeal for Action](https://scholariq.org/papers/catastrophic-floods-in-pakistan-an-urgent-appeal-for-action/)
- [Maternal health in Afghanistan amidst current crises – A neglected concern](https://scholariq.org/papers/maternal-health-in-afghanistan-amidst-current-crises-a-neglected-concern/)
- [Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/switching-to-tenofovir-therapy-versus-continuation-of-entecavir-for-patients/)
- [Efficacy and Safety of 10‐Day Versus 14‐Day Bismuth‐Containing Quadruple Therapy for <scp><i>Helicobacter pylori</i></scp> Eradication: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/efficacy-and-safety-of-10-day-versus-14-day-bismuth-containing-quadruple-therapy/)
- [Comparison of Prophylactic Transcatheter Arterial Embolization and Standard Therapy in High-Risk Non-Variceal Upper Gastrointestinal Bleeding: A Meta-Analysis](https://scholariq.org/papers/comparison-of-prophylactic-transcatheter-arterial-embolization-and-standard/)
- [Peroxisome Proliferator‐Activated Receptor (<scp>PPAR</scp>) Agonists for Patients With Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid (<scp>UDCA</scp>): A Systematic Review and Meta‐Analysis of Randomized Controlled Trials](https://scholariq.org/papers/peroxisome-proliferator-activated-receptor-scp-ppar-scp-agonists-for-patients/)
- [Assessing the effectiveness of texture and color enhancement imaging versus white‐light endoscopy in detecting gastrointestinal lesions: A systematic review and meta‐analysis](https://scholariq.org/papers/assessing-the-effectiveness-of-texture-and-color-enhancement-imaging-versus/)
- [EUS-guided enterocolostomy with lumen-apposing metal stents for palliative management of malignant bowel obstruction: a systematic review and meta-analysis](https://scholariq.org/papers/eus-guided-enterocolostomy-with-lumen-apposing-metal-stents-for-palliative/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Colorectal Cancer Screening and Detection](https://scholariq.org/topics/colorectal-cancer-screening-and-detection/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

## Researcher university

- [Pennsylvania State University](https://scholariq.org/institutions/pennsylvania-state-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.